HC Wainwright & Co. Downgrades Decibel Therapeutics to Neutral
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis has downgraded Decibel Therapeutics (NASDAQ:DBTX) from Buy to Neutral.
August 09, 2023 | 2:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Decibel Therapeutics has been downgraded from Buy to Neutral by HC Wainwright & Co.
The downgrade from Buy to Neutral by a reputable analyst firm like HC Wainwright & Co. could potentially lead to a decrease in investor confidence in Decibel Therapeutics, which may negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100